John Staffurth

17.4k citations

117 papers · 4.4k indexed · 1 hit paper · h-index 31

Impact in

Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Radiation top 0.5%
- Advanced Radiotherapy Techniques

Papers in

Radiation 34
- Advanced Radiotherapy Techniques 34
Pulmonary and Respiratory Medicine 89
- Prostate Cancer Treatment and Research 52
- Prostate Cancer Diagnosis and Treatment 32
- Lung Cancer Diagnosis and Treatment 13
- Gastric Cancer Management and Outcomes 10

Co-authors: Malcolm D. Mason Aled Clayton Joanne L. Welton Howard I. Scher Karim Fizazi Thian Kheoh Robert J. Jones Johann S. de Bono
Journals: Journal of Clinical Oncology (22 papers)Clinical Oncology (11 papers)International Journal of Radiation Oncology*Biology*Physics (10 papers)Radiotherapy and Oncology (9 papers)Radiation Oncology (5 papers)
Partner nations: United Kingdom United States Canada

In The Last Decade

John Staffurth

114 papers receiving 4.3k citations

Hit Papers

align trajectories log scale

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study 2012 · 1.0k citations

Peers

Countries citing papers authored by John Staffurth

Since Specialization

Citations

This map shows the geographic impact of John Staffurth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Staffurth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Staffurth more than expected).

Fields of papers citing papers by John Staffurth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Staffurth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Staffurth. The network helps show where John Staffurth may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John Staffurth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Staffurth Line = papers co-authored together John Staffurth links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate Cancer Cells ·冰雨, 国家公務員倫理審査会事務局, Nicholas Bullock, Kathryn Gilroy, Fangjing Zhang, Radhika A. Patel, Taizo MORISHITA, Valérie S. Méniel, Gillian Seaton, Howard Kynaston, Richard Clarkson, Toby J. Phesse, Peter S. Nelson, Michael C. Haffner, John Staffurth, Helen Pearson	2024	1
2	Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trial SHILAP Revista de lepidopterología ·寿珍陆, Emma Clark, Lilik Wahyono, Shao Qiang Li, Holly Fisher, Leila De Vito, Ruth Wood, Helen Hancock, Jiarong Liu, V.V. Valanju, Rebecca Maier, J. Jeffrey Marshall, Robert W. Chandler, Amit Bahl, Simon J. Crabb, Suneil Jain, Ian Pedley, Robert J. Jones, John Staffurth, Rakesh Heer	2023	4
3	Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response JNCI Cancer Spectrum ·Chris Parker, Nina Tunariu, Holly Tovey, Roberto Alonzi, Matthew Blackledge, Gary Cook, Sue Chua, Yong Du, S. Hafeez, Iain Murray, Anwar R. Padhani, John Staffurth, Alison Tree, José Benito Vázquez Dorio, Alba Ribera Martínez, Andra Curcean, Peter Chatfield, Sophie Perry, Dow‐Mu Koh, Emma Hall	2023	3
4	Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT Health Technology Assessment ·Douglas Adamson, Jane Blazeby, Raphaël Lardeux, Chris Hurt, Gareth Griffiths, Annmarie Nelson, Bernadette Sewell, Mari Jones, I. Palomares Casado, Deborah Fitzsimmons, Lisette Nixon, Jim Fitzgibbon, Stephen Thomas, Summers Tyler, Tom Crosby, John Staffurth, Anthony Byrne	2021	3
5	Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial The Lancet. Gastroenterology & hepatology ·Douglas Adamson, Anthony Byrne, Raphaël Lardeux, Jane Blazeby, Gareth Griffiths, Annmarie Nelson, Bernadette Sewell, Mari Jones, I. Palomares Casado, Deborah Fitzsimmons, Lisette Nixon, Jim Fitzgibbon, Stephen Thomas, Summers Tyler, Tom Crosby, John Staffurth, Chris Hurt	2021	26
6	Comparative Healthcare Research Outcomes of Novel Surgery in prostate cancer (IP4-CHRONOS): A prospective, multi-centre therapeutic phase II parallel Randomised Control Trial Contemporary Clinical Trials ·Deepika Reddy, Taimur T. Shah, Tim Dudderidge, Stuart McCracken, Manit Arya, Fe Zhuang, Mark Emberton, Francesca Fiorentino, Emily Day, A Toby Prevost, John Staffurth, Matthew R. Sydes, Mathias Winkler, Hashim U. Ahmed	2020	17
7	PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018) Clinical and Translational Radiation Oncology ·Isabel Syndikus, Clare Cruickshank, John Staffurth, Alison Tree, Ann Henry, Olivia Naismith, Helen Mayles, Erin Koletsis, Shama Hassan, Stephanie Brown, Núria Porta, Clare Griffin, Emma Hall	2020	31
8	The ALERT-B questionnaire: A screening tool for the detection of gastroenterological late effects after radiotherapy for prostate cancer Clinical and Translational Radiation Oncology ·D. J. J. Farnell, John Staffurth, Stephanie Sivell, Sam H. Ahmedzai, Jervoise Andreyev, 真実斉藤, David S. Sanders, Catherine Ferguson, 河村芳朗, Ann Muls, Elizabeth Laycock, Stuart Campbell, Sophia Taylor, Annmarie Nelson	2020	4
9	Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol BMJ Open ·Emma Clark, Lilik Wahyono, Shao Qiang Li, Holly Fisher, Denise Howel, Leila De Vito, Ruth Wood, Helen Hancock, Rebecca Maier, J. Jeffrey Marshall, Amit Bahl, Simon J. Crabb, Suneil Jain, Ian Pedley, Robert J. Jones, John Staffurth, Rakesh Heer	2019	6
10	ATLAAS - Investigation into the Incorporation of Morphological Data on Automated Segmentation [Abstract] ORCA Online Research @Cardiff (Cardiff University) ·Craig Parkinson, P. Whybra, John Staffurth, C. Marshall	2018	1
11	Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL) International Journal of Radiation OncologyBiologyPhysics ·David P. Dearnaley, Clare Griffin, Rebecca Lewis, Philip Mayles, Helen Mayles, Olivia Naismith, Victoria Harris, Christopher Scrase, John Staffurth, Isabel Syndikus, Anjali Zarkar, Daniel Ford, Y. Rimmer, Gail Horan, Vincent Khoo, J. Frew, Ramachandran Venkitaraman, Emma Hall	2018	43
12	Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: Analysis of the on-trial cases for the SCALOP trial Radiotherapy and Oncology ·Emmanouil Fokas, Emiliano Spezi, Neel Patel, Chris Hurt, Lisette Nixon, Kwun-Ye Chu, John Staffurth, Ross A. Abrams, Somnath Mukherjee	2016	23
13	O-003 Long-term outcome from the SCALOP trial: a multi-centre randomized phase II trial of gemcitabine or capecitabine-based chemoradiation (CRT) for locally advanced pancreatic cancer (LAPC) Annals of Oncology ·Chris Hurt, John Bridgewater, Stephen Falk, S. Cummins, Harpreet Wasan, Tom Crosby, G. Radhakrishna, Catherine Jephcott, Rajarshi Roy, Alec McDonald, Ruby Ray, Geetha Joseph, John Staffurth, R. A. Abrams, Gareth Griffiths, Tim Maughan, Somnath Mukherjee	2016	6
14	Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells—A Key Role for Heat-Shock Protein 70 and Receptor CD91 Cancer Immunology Research ·Josephine Salimu, Lisa K. Spary, Saly Al‐Taei, Aled Clayton, Malcolm D. Mason, John Staffurth, Zsuzsanna Tabi	2015	34
15	The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation Radiation Oncology ·Laura Sheckter, John Staffurth, S. Warren, Mike Partridge, Chris Hurt, Emiliano Spezi, Sarah Gwynne, M. Hawkins, T. Crosby	2015	4
16	Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial The Lancet Oncology ·T. Crosby, Chris Hurt, Stephen Falk, Simon Gollins, Somnath Mukherjee, John Staffurth, Ruby Ray, Nadim Bashir, John Bridgewater, J I Geh, David Cunningham, Jane Blazeby, Rajarshi Roy, Tim Maughan, Gareth Griffiths	2013	272
17	Time to prostate specific antigen (PSA) nadir may predict rapid relapse in men with metastatic castration-resistant prostate cancer (CRPC) receiving docetaxel chemotherapy Medical Oncology ·Adinda Aulia Ar-ramdhani, Jiménez Garrido Manuel Cecilio, Jessica Evans, M. Button, Satish Kumar, Nachi Palaniappan, John Staffurth, Jacob Tanguay, J.F. Lester	2013	15
18	UK Guidelines for the Safe Delivery of Intensity-modulated Radiotherapy Clinical Oncology ·R. Mackay, John Staffurth, Andrew Poynter, 김세중	2010	9
19	The effect of planning algorithms in oesophageal radiotherapy in the context of the SCOPE 1 trial Radiotherapy and Oncology ·B. M Owat, Summers Tyler, Julio Cesar Hoshi Kurimoto, Tom Crosby, John Staffurth	2009	8
20	Radiotherapy for early prostate cancer ORCA Online Research @Cardiff ·John Staffurth, Malcolm D. Mason	2008	1

About John Staffurth

John Staffurth is a scholar working on Radiation, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Oncology and Cancer Research, having authored 117 papers that have together received 4.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (52 papers), Advanced Radiotherapy Techniques (34 papers), Prostate Cancer Diagnosis and Treatment (32 papers), Esophageal Cancer Research and Treatment (16 papers), Radiopharmaceutical Chemistry and Applications (15 papers), Lung Cancer Diagnosis and Treatment (13 papers), Gastric Cancer Management and Outcomes (10 papers) and Radiomics and Machine Learning in Medical Imaging (10 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.8k citations), Radiation (728 citations), Cancer Research (885 citations), Radiology, Nuclear Medicine and Imaging (1.2k citations) and Oncology (1.1k citations). John Staffurth has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Malcolm D. Mason, Aled Clayton, Joanne L. Welton, Howard I. Scher, Karim Fizazi, Thian Kheoh, Robert J. Jones, Johann S. de Bono, Arturo Molina and Stephen Harland. Their work appears in journals such as Journal of Clinical Oncology, Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology and Radiation Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact